Skip to main content
Signal8
CORNELIUS JAMES M profile photo

James M. Cornelius

CIK: 0001198959

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MBX Biosciences, Inc. logo
MBX

MBX Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • MBX Biosciences, Inc. logo
    MBX

    MBX Biosciences, Inc.

    Jun 5, 2025
    Award(A)

    Stock option (right to buy)

    Direct
    16K shares-
  • MBX Biosciences, Inc. logo
    MBX

    MBX Biosciences, Inc.

    Sep 16, 2024
    Conversion(C)
    Direct
    102.1K shares-
  • MBX Biosciences, Inc. logo
    MBX

    MBX Biosciences, Inc.

    Sep 12, 2024
    Award(A)

    Stock Option (Right to Buy)

    Direct
    16K shares-

1-3 of 3

About CORNELIUS JAMES M

CORNELIUS JAMES M (SEC CIK 0001198959) files insider reports with the SEC as Director of MBX Biosciences, Inc. (MBX).

Signal8 holds 4 ownership filings by CORNELIUS JAMES M (1 Form 3, 3 Form 4), filed between Sep 12, 2024 and Jun 6, 2025. Those filings report 3 transactions, from Sep 12, 2024 to Jun 5, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on CORNELIUS JAMES M's filings is in CARMEL, IN.

Recent filings by CORNELIUS JAMES M

  • Jun 5, 2025: Grant or award of MBX derivative securities (Form 4, code A).
  • Sep 16, 2024: Conversion of MBX shares (Form 4, code C).
  • Sep 12, 2024: Grant or award of MBX derivative securities (Form 4, code A).

Other insiders filing for MBX Biosciences, Inc. (MBX)

How to read Form 4 transaction codes